by Eric Christianson | May 31, 2026 | Endocrine Medication and Disease State Clinical Pearls
Weight loss medications can differ substantially in efficacy, adverse effect profiles, and monitoring considerations, making patient-specific counseling essential. In this blog post, I share common practice pearls for weight loss medications. GLP-1 Type Agents Slow...
by Eric Christianson | May 27, 2026 | Gastrointestinal Case Studies
NSAIDs are a notorious cause of GI bleeds. This is something that I am significantly concerned about as a geriatric consultant pharmacist. In this blog post, I share 3 examples of NSAIDs causing GI bleeds that I have seen in practice. Scenario 1 – Duplicate...
by Eric Christianson | May 24, 2026 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
When you are studying for your exams, be sure to take a good, hard look at paroxetine. While it can be effective for anxiety disorders, panic disorder, depression, and PTSD, its pharmacokinetic and adverse effect profile creates several important clinical...
by Eric Christianson | May 20, 2026 | Renal, Urology, and Electrolytes Medication and Disease State Clinical Pearls
A patient I was following had a sodium level of 132 mEq/L and a student asked me how much we should worry about this? It is a bit of a deep question, but in general, a slightly low sodium level of 132 is not going to be a life-threatening situation. Here are some of...
by Eric Christianson | May 17, 2026 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
If you follow geriatrics or are board-certified, you probably know that nortriptyline is generally preferred over amitriptyline in this patient population. It’s kind of weird to think there is such a difference because nortriptyline is an active metabolite of...
